This will turn into a profitable growth stock in 2017 and beyond.
Capital structure is not ideal but easily overcome with good margins and profitability. Cosmetic and farnesene/squalene will lead the way with collaborations kicking in somewhere down the rode.
This is a ride it all the way company and 2017 should right the capital structure and everything will fall in place. Don't be foolish, get your load under a dollar...